Patent · US Active

Pyridine carbamates and their use as GLUN2B receptor modulators

US11447503B2 · kind B2 · utility

2Cited by

15References

33Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Christine F. Gelin · San Diego, US
Heather R. Coate · San Diego, US
Brice M. Stenne · Village of La Jolla, US
Curt A. Dvorak · Poway, US

Key dates

Filing date	Jun 12, 2020
Grant date	Sep 20, 2022
Priority date	—
Expiry date	Nov 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by GluN2B receptor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.